CtDNA based MRD detection correlates with outcomes in resected biliary tract cancers patients- A RWE study. The evidence is building up in BTC and continues to grow in GI cancers. Cholangiocarcinoma Foundation #ccf2024 Stacie Lindsey Melinda Bachini

Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

#Cancer #ColorectalCancer #OncoDaily #Oncology #Xfluencers #Cancer Care

oncodaily.com/41402.html

Join our webinar to hear our panel discuss data recently presented at ASCO #GI24 and how ctDNA analysis can help bring clarity in the adjuvant and surveillance settings. Register: ow.ly/obu250Qy2E3

Adham Jurdi Pashtoon Kasi MD, MS

Wrap up of our ctDNA evidence presented at ASCO #GU24 .
Our superstar leader Shruti Sharma and great collaborator Arnab Basu present our latest RWE on the utility of ctDNA in Variant Histology MIBC. Overall, ctDNA status post-cystectomy continues to show strong prognostic…

👇🏼👇🏼

#GI24 Great way to wrap up ASCO with a nice piece on #ctDNA at🗞️ #ASCODailyNews combining the two studies:
✔️BESPOKE CRC
✔️Dynamic-2 Jeanne Tie

🔑 is integrating into clinical decision making. Putting things into context. Not in isolation.

OncoAlert

dailynews.ascopubs.org/do/studies-con…

Updated results of GALAXY ctDNA cohort were presented today at ASCO GI 2024 Conference. These results will shape the future of colorectal cancer care. #GI24 Natera Oncology

Updated 2-yr analysis of GALAXY observational #ctDNA cohort in StI-IV #CRC shows sustained predictive power or ctDNA+ for inferior DFS, sustained ctDNA clearance w/superior DFS, 98% of those w/transient clearance became ctDNA+ by 18 mos post surgery #GI24 OncoAlert

Congrats to lyudmyla berim and all the RutgersCancerInstNJ GI Oncology docs and research staff for co-authorship on the excellent ASCO #GI24 presentation of the BESPOKE trial of ctDNA as presented by Pashtoon Kasi MD, MS 👉great data on MRD testing 👈 to direct adjuvant #CRC Rx

Pashtoon Kasi MD, MS #BESPOKE ctDNA is predictive of DFS, benefit for adjuvant therapy seen in #ctDNA +, sustained clearance is associated w/superior DFS, and allowed for oligo-met directed therapy in 40% of pts who recurred, MRD #crcsm #gi24 OncoAlert

👇🏾This is so cool.
#GI24

2 of the🔝trending clinical trials ASCO and study results are ours!

✔️ #ctDNA BESPOKE CRC
&
✔️ #NEST -1 using BOT/BAL novel CTLA-4⛔️ in patients with colorectal cancers.

Can’t wait till Saturday to present these in more detail.
OncoAlert brunolarvol.eth